This inventor holds 1 USPTO granted patent. Top assignees: Georgetown University, Sepracor, Inc.. Active years: 1994.
Company Filing History:
1 out of 496 
1 out of 322 
Years Active: 1994
Title: Yiwang Chen: Innovator in Allergy Treatment
Introduction
Yiwang Chen is a notable inventor based in Silver Spring, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of allergic disorders. His innovative approach focuses on utilizing metabolic derivatives of terfenadine, a compound known for its antihistamine properties.
Latest Patents
Yiwang Chen holds 1 patent for his work titled "Methods and compositions for treating allergic disorders and other." This patent discloses methods and compositions that utilize metabolic derivatives of terfenadine for treating allergic disorders while minimizing the adverse effects associated with the original compound. The derivatives are also effective in treating retinopathy and other small vessel disorders related to diabetes mellitus. Additionally, they can be used for conditions such as asthma, motion sickness, and vertigo, without the negative side effects linked to terfenadine. Furthermore, these derivatives, when combined with non-steroidal anti-inflammatory agents or other analgesics, are beneficial for alleviating symptoms of cough, cold, flu, and associated discomfort.
Career Highlights
Throughout his career, Yiwang Chen has worked with reputable organizations, including Sepracor, Inc. and Georgetown University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative treatments.
Collaborations
Yiwang Chen has collaborated with esteemed colleagues such as Raymond L. Woosley and James W. Young. These partnerships have further enriched his research and development efforts in the field of allergy treatment.
Conclusion
Yiwang Chen's innovative work in the treatment of allergic disorders showcases his dedication to improving patient outcomes. His patented methods and compositions represent a significant advancement in medical science, highlighting the importance of continued research and innovation in healthcare.